SELLAS Life Sciences Group (SLS) Institutional Ownership → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free SLS Stock Alerts $1.47 +0.10 (+7.30%) (As of 05/15/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$5.97MNumber ofInstitutional Sellers(last 12 months)0 Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024 Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366% 4/26/2024 Opus Capital Group LLC200,600$203K0.0%+48.6%0.356% 2/13/2024Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024 Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% 9/12/2023Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% 5/11/2023 Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 1/18/2023 Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 2/14/2022 GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022 Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021 Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021 Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021 Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021 Northern Trust Corp24,605$273K0.0%+35.9%0.163% 8/13/2021 Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021 Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021 Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% 8/12/2021 Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021 Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, the following institutional investors and hedge funds held shares of SELLAS Life Sciences Group shares: Anson Funds Management LP ($4.88M), Highbridge Capital Management LLC ($2.58M), Armistice Capital LLC ($869K), Empery Asset Management LP ($623K), and Opus Capital Group LLC ($203K), Prosperity Financial Group Inc. ($47K).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? The following institutional investors have purchased SELLAS Life Sciences Group stock in the last 24 months: Anson Funds Management LP ($4.83M), Highbridge Capital Management LLC ($1.81M), Armistice Capital LLC ($820K), Opus Capital Group LLC ($185.77K), and Prosperity Financial Group Inc. ($29.80K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 7,672,994 shares in the last 24 months. This purchase volume represents approximately $8.60M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Empery Asset Management LP ($619.52K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 619,518 shares in the last 24 months. This volume of shares sold represents approximately $1.25M in transactions. Related Companies: vTv Therapeutics Major Shareholders Anebulo Pharmaceuticals Major Shareholders Reviva Pharmaceuticals Major Shareholders Leap Therapeutics Major Shareholders InflaRx Major Shareholders Affimed Major Shareholders Rallybio Major Shareholders YS Biopharma Major Shareholders Tempest Therapeutics Major Shareholders LifeVantage Major Shareholders This page (NASDAQ:SLS) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.